Testing effectiveness (Phase 2)UnknownNCT05024266
What this trial is testing
Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma
Who this might be right for
Lung Squamous Cell CarcinomaNeoadjuvant TherapyImmunotherapy
First Affiliated Hospital of Zhejiang University 30